The Food and Drug Administration (FDA) is offering a federal grant opportunity titled "OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed." This initiative aims to enhance the FDA's Office of Minority Health and Health Equity (OMHHE) efforts by funding innovative and community-based strategies for education, outreach, and public awareness regarding the potential risks associated with over-the-counter skin lightening products containing hydroquinone and/or mercury. The grant has a fixed award amount of $250,000, with no cost-sharing or matching requirements, and is open to unrestricted applicants. Interested parties can contact Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610 for further information. The opportunity is forecasted for the fiscal year 2024, with the last update provided on December 12, 2023.